Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Intellia Prices up to $345m Public Offering at $45.8/Share (2022-11-30)
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR-based technologies, announced today the pricing of an underwritten public offering of 6,550,219 shares ...
MedinCell Receives $4m from Gates Foundation for mdc-WWM (2022-11-30)
> MedinCell has received an additional US$ 4 million payment from the Bill & Melinda Gates Foundation > This amount is intended to finance the next steps of MedinCell’s program mdc-WWM in readiness to initiate the first clinical trial end of 2023 > It follows...
AstraZeneca Acquires Neogene: up to $320m with $200m Upfront (2022-11-29)
Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumours AstraZeneca today announced an agreement to acquire Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company p...
Envisagenics Announces Research Collaboration with BMS (2022-11-29)
Collaboration will leverage Envisagenics’ SpliceCore® AI platform for accelerated discovery and development of oncology therapeutic candidates Envisagenics, an Artificial Intelligence (“AI”)-driven biotechnology company that delivers therapies for RNA splici...
Full-Life Technologies Acquires Focus-X Tx for up to $245m (2022-11-29)
Acquisition accelerates Full-Life’s transformation into clinical stage radiopharmaceutical company, leveraging its European-focused Radiotechnology and Development Platform Full-Life Technologies, a fully integrated global radiotherapeutics company, today anno...
V7 Raises $33m Series A to Help Build Robust AI, Faster (2022-11-28)
V7 announces $33m Series A financing co-led by AI-focused Radical Ventures and Temasek, with participation from Air Street Capital, Amadeus Capital, and Partech. > V7, the data engine for AI, announces a $33m Series A funding round, co-led by Radical Ventures an...
Strand Therapeutics Extends Series A with $45m to $97m (2022-11-28)
-- Company’s platform aims to create programmable, long-acting mRNA therapies that offer curative treatments for cancer and beyond -- -- Series A1 round led by new investor FPV Ventures -- Strand Therapeutics, the programmable mRNA company developing curati...
Oxford Biomedica Appoints Frank Mathias as CEO (2022-11-22)
Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell therapy group, today announces the appointment of Dr Frank Mathias as Chief Executive Officer (CEO) and Board Director, effective March 2023. Dr Mathias brings world-cl...
Catalym Closes €50m Series C Led by Brandon Capital & Jeito (2022-11-22)
CatalYm today announced the close of a EUR 50 million (USD 49 million) Series C financing round. The oversubscribed round was co-led by new investors, Brandon Capital and Jeito Capital with participation from existing investors Forbion, Novartis Venture Fund, Vesal...
G1 Therapeutics Closes $50.05m Public Offering at $6.5/Share (2022-11-22)
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the closing of an underwritten public offering of 7,700,000 shares of its common stock at a public offering price of $6.50 per share. G1 Therapeutics received $50,050,000 in ...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture Campus Berlin-Buch GmbH GMP Basic Course Online 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]